ATH 33.3% 0.4¢ alterity therapeutics limited

cowan conference, page-24

  1. 1,365 Posts.
    I'm interested to know if the extension will count in a significant way to the scientific case they put forward to the FDA - namely, if patients on the placebo are put onto the good stuff, even if they derived some placebo benefit, the real benefit should be clear as day, in a way that significantly reduces any doubt.


    In the words of the late Big Kev: I'M EXCITED!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.